Glucagon-like peptide-1 (GLP-1) is a hormone released in your intestines in response to eating
This is particularly relevant in the cancer context, where the tumor microenvironment often promotes oxidative stress and altered cellular signaling pathways, contributing to the rapid turnover of RBCs
While probiotics have a generally favorable safety profile, individual reactions vary
Common stomach effects In pooled STEP 1-3 data on the 2.4 mg dose, nausea occurred in 43.9% of participants (vs 16.1% on placebo), diarrhea in 29.7% (vs 15.9%), vomiting in 24.5% (vs 6.3%), and constipation in 24.2% (vs 11.1%)
Attend A&E or call 999 if you experience severe unrelenting abdominal pain, persistent vomiting preventing fluid intake, abdominal distension with severe pain, no bowel movements or wind for 2448 hours with pain, signs of dehydration, fever with abdominal symptoms, or blood in vomit or stool